Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates
06:55pm, Thursday, 05'th Nov 2020
Adma Biologics (ADMA) delivered earnings and revenue surprises of 9.52% and 7.64%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
ADMA Biologics Reports Third Quarter 2020 Financial Results and Business Highlights
04:05pm, Thursday, 05'th Nov 2020
Generated Total Revenues of $ 28. 3 Million for the First Nine Months of 2020 , Reflecting a 63 % Increase Over the Same Prior Year Period
ADMA Biologics to Report Third Quarter 2020 Financial Results and Business Highlights on November 5, 2020
07:00am, Thursday, 29'th Oct 2020
Conference Call Scheduled for Thursday, November 5, 2020, at 4:30 p.m. ET Conference Call Scheduled for Thursday, November 5, 2020, at 4:30 p.m. ET
What's in Store for ADMA Biologics' (ADMA) Q3 Earnings?
12:55pm, Wednesday, 28'th Oct 2020
On ADMA Biologics' (ADMA) third-quarter earnings call, investor focus will be on the sales performance of its newly approved immunoglobulin products, Asceniv and Bivigam.
Analysts Estimate Adma Biologics (ADMA) to Report a Decline in Earnings: What to Look Out for
12:32pm, Wednesday, 28'th Oct 2020
Adma Biologics (ADMA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ADMA Biologics Announces Presentation on Respiratory Viral Infections and New Data on S. Pneumoniae at IDWeek 2020
07:00am, Wednesday, 21'st Oct 2020
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 21, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated
Is the Options Market Predicting a Spike in ADMA Biologics (ADMA) Stock?
09:16am, Wednesday, 07'th Oct 2020
Investors need to pay close attention to ADMA Biologics (ADMA) stock based on the movements in the options market lately.
ADMA Biologics (ADMA) Surges: Stock Moves 8.6% Higher
08:41am, Thursday, 01'st Oct 2020
ADMA Biologics (ADMA) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
ADMA Biologics to Participate in Morgan Stanley Virtual Healthcare Conference
07:00am, Wednesday, 09'th Sep 2020
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 09, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedica
ImmunoRank Offers a Faster, Simpler, More Cost Effective Way to Identify High Titer Convalescent Plasma for Use in Both Treating COVID-19 Patients and for Creating COVID-19 Hyperimmune Globulins
ADMA Biologics to Participate in Upcoming Investor Conferences
07:00am, Wednesday, 02'nd Sep 2020
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 02, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedica
Biotech Boom: The Race for COVID-19 Vaccines
03:58pm, Tuesday, 01'st Sep 2020
The pandemic highlights how far medical science has come. It also highlights how exciting the future is.
Are Options Traders Betting on a Big Move in ADMA Stock?
08:55am, Tuesday, 25'th Aug 2020
Investors need to pay close attention to ADMA stock based on the movements in the options market lately.
Is ADMA Biologics a Good Coronavirus Stock to Buy Now?
06:37am, Tuesday, 25'th Aug 2020
Shares of ADMA Biologics are on the move following the FDA's authorization of convalescent plasma for the treatment of COVID-19 patients.
What You Need to Know About the "Breakthrough" Coronavirus Therapy Heralded by President Trump
06:04am, Tuesday, 25'th Aug 2020
Convalescent plasma holds promise for treating COVID-19, but it's still unproven.
